EuroPac International Value A Current Cash

The latest current cash for EPIVX is $130M as of December 2023. That compares with $130M in the prior-year period — up 0.4% year over year. Investors often review this figure alongside EuroPac International Value A's historical trend and sector peers before judging valuation or financial health.

Over the past year, EPIVX's current cash moved from $130M to $130M — a 0.4% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in EuroPac International Value A's operating scale or balance-sheet position.

A current cash figure of $130M for EPIVX is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting EPIVX's current cash ($130M), review year-over-year change from $130M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.